Discovering Novel Mechanisms Of Breast Cancer Brain Metastasis Using High Throughput Mass Spectrometry-based Technology | 2943
Journal of Computer Science & Systems Biology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Dr. Weljie is currently the co-Director of the Metabolomics Research Centre at the University of Calgary, where his primary focus is developing a
program in cancer metabolism using a combination of highly sensitive mass spectrometry methods and quantitative nuclear magnetic resonance
spectroscopy. In addition to methods development, projects in Dr. Weljie?s group are focused on i) elucidating the connection between energy and
lipid metabolism and cancer, and ii) the impact of environmental toxicants on carcinogenesis and cellular proliferation. Dr. Weljie?s group is also
involved in several multidisciplinary clinical collaborations focusing on serum metabolomics in cancer. This program builds on his previous expertise
in nuclear magnetic resonance metabolomics, which has been productive in both methods development and elucidating biological phenomena both
at the University of Calgary, with Chenomx Inc, and at the University of Cambridge in the lab of Dr. Jules Griffin.
Dr. Chen received her Ph.D. degree from the Department of Molecular Pathology at the University of California, San Diego in 2002. Then, she
pursued her postdoctoral training at the Scripps Research Institute in Dr. John Yates? laboratory. Currently, she is a faculty member in the Department
of Pharmacological Sciences and the Scientific Director of the Proteomics Center at the Stony Brook University. Using the cutting-edge mass
spectrometry-based proteomic techniques, her current research focuses on elucidating mechanisms of tissue-specific breast cancer metastasis and
identifying protein targets to eradicate the growth of distal breast cancer metastasis. She is also developing new proteomics techniques to perform
biomarker discovery using archived tissues from human patients.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals